https://www.selleckchem.com/pr....oducts/mpp-dihydroch
The United States Food and Drug Administration (FDA) recently issued a Drug Safety Communication requiring Boxed Warning updating and other changes in order to improve the safe use of the benzodiazepine drug class. These changes were prompted because 'The current prescribing information for benzodiazepines does not provide adequate warnings about [the] serious risks and harms associated with these medicines so they may be prescribed and used inappropriately'. The FDA Communication points out that benzodiazepines can be an im
Like
Comment
Share
